Header Logo

Connection

MUZAFFAR H QAZILBASH to Blood Transfusion, Autologous

Back to Details
This is a "connection" page, showing publications MUZAFFAR H QAZILBASH has written about Blood Transfusion, Autologous.
MUZAFFAR H QAZILBASH
Connection Strength
0.385
Blood Transfusion, Autologous
  1. A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid. Cancer. 2012 May 01; 118(9):2507-15.
    View in: PubMed
    Score: 0.385
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.